The experimental program aims to align President Donald Trump’s most-favored-nation drug price targets with the prices charged to state Medicaid programs.
by is licensed under
Follow us
Read our latest news on any of these social networks!
Get latest news delivered daily!
We will send you breaking news right to your inbox